Please email the editors at 'theniche at nature.com' to propose new posts.

« Papers: Reprogramming [cells], resetting [expression], and revising [ideas on cell fate] | Main | Stem cells in fat might help arthritic dogs walk »

Bookmark in Connotea

Pfizer dips a toe into cell therapy

Here’s some news on the commercial front that shows stem cell therapy moving forward. The pharmaceutical giant Pfizer has made a teeny-tiny investment in stem cells, according to an article in Forbes.

Pfizer is financing a company called EyeCyte, which hopes to use cells from the blood and bone marrow to repair damaged blood vessels in the eyes of patients suffering from diabetes and macular degeneration. Pfizer spends over $8 billion in research and development and is investing $3 million in EyeCyte in exchange for having part ownership of the company and being its sole pharmaceutical partner. If the therapyworks, though, the payoff could be huge: biologics against macular degeneration have proved big business.


Posted by Monya Baker on June 25, 2008
Categories: Industry, Regenerative medicine | | Comments (1) | TrackBacks (0)

TrackBack

TrackBack URL for this entry:
http://blogs.nature.com/cgi-bin/mt/mt-tb.cgi/5465

Comments

The pharmaceutical giant Pfizer has made a teeny-tiny investment in stem cells, according to an article in Forbes, the news sounds. Well! Nothing strange, since utilizing stem cells could be a businness.But also possibly dangerous, as i wrote in this webbsite at URLhttp://blogs.nature.com/reports/theniche/2008/04/stemcell_skin_creams_a_san_die.html#comments .Does Pfizer know my criticism on the present, therapeutic use of stem cells? I hope YES, in the interest of mankind.

Posted by: Sergio Stagnaro MD | June 26, 2008 09:18 AM

Post a comment

Comments will be reviewed by the blog editors before being published, mainly to ensure that spam and irrelevant material (such as product advertisements) are not published . Please keep your comment brief. Excessively long or offensively phrased entries will be edited.

We strongly encourage you to use your real, full name. E-mail addresses are required in case we need to discuss your comment with you directly. We won't publish your e-mail address unless you request it.

Please enter the numbers you see below - this helps us to avoid spam. If you are having trouble with this system, you can send your comment by e-mail to 'theniche at nature.com'.

please enter code

Search